Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anticancer Res ; 25(1A): 213-24, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15816541

RESUMO

BACKGROUND: p53 is the most frequently mutated gene in human cancers and its functional integrity is an important predictor of treatment response and clinical outcome. The majority of mutations found in different types of cancer cluster within the DNA binding domain encoded by exons 5-8. In clinical specimens the functional status of p53 is, therefore, often evaluated by direct mutation analysis of exons 5-8 or indirectly by immunostaining and evaluation of the subcellular localization pattern or protein accumulation. MATERIALS AND METHODS: In a panel of glioma cell lines, the status of the P53 gene was analyzed by temperature gradient gel electrophoresis (TGGE) of exons 5-8 and direct sequencing of all p53 exons. The nuclear accumulation of p53 in unstressed cells was assessed by immunostaining. These data were correlated with stress induction of the p53 protein, nuclear translocation and a direct determination of the transcriptional activity of endogenous p53 protein and induction of p53 target genes. RESULTS: Our analysis demonstrated that a p53 gene mutation analysis limited to exons 5-8 and analysis of immunostaining patterns can not serve as reliable predictors of functional p53 in tumor cells. Conversely, in some presumably rare cases, the transcriptional activity of p53 may be retained in tumor cells in the presence of a mutation and a pathological immunostaining pattern. In our analysis, the constitutive dephosphorylation at Ser 376 correlated with the nuclear accumulation of p53, but not with the transcriptional activity of the protein. This suggests that constitutive dephosphorylation at Ser376 may be one of the factors determining stabilization of mutant and wild-type p53, which is frequently observed in glial tumors. CONCLUSION: The incidence of a dysfunctional p53 protein in gliomas may be higher than expected, based on a single parameter evaluation by mutation analysis of exons 5-8 or assessment of p53 accumulation and subcellular localization by immunostaining.


Assuntos
Neoplasias Encefálicas/genética , Neoplasias Encefálicas/metabolismo , Glioma/genética , Glioma/metabolismo , Proteína Supressora de Tumor p53/fisiologia , Linhagem Celular Tumoral , Núcleo Celular/metabolismo , Eletroforese/métodos , Éxons/genética , Genes p53/genética , Humanos , Mutação , Fosforilação , Frações Subcelulares/metabolismo , Proteína Supressora de Tumor p53/genética , Proteína Supressora de Tumor p53/metabolismo
2.
Neuro Oncol ; 1(1): 3-13, 1999 01.
Artigo em Inglês | MEDLINE | ID: mdl-11550298

RESUMO

The capacity of glial tumor cells to migrate and diffusely infiltrate normal brain compromises surgical eradication of the disease. Identification of genes associated with invasion may offer novel strategies for anti-invasive therapies. The gene for TXsyn, an enzyme of the arachidonic acid pathway, has been identified by differential mRNA display as being overexpressed in a glioma cell line selected for migration. In this study TXsyn mRNA expression was found in a large panel of glioma cell lines but not in a strain of human astrocytes. Immunohistochemistry demonstrated TXsyn in the parenchyma of glial tumors and in reactive astrocytes, whereas it could not be detected in quiescent astrocytes and oligodendroglia of normal brain. Glioma cell lines showed a wide range of thromboxane B2 formation, the relative expression of which correlated with migration rates of these cells. Migration was effectively blocked by specific inhibitors of TXsyn, such as furegrelate and dazmegrel. Other TXsyn inhibitors and cyclooxygenase inhibitors were less effective. Treatment with specific inhibitors also resulted in a decrease of intercellular adhesion in glioma cells. These data indicate that TXsyn plays a crucial role in the signal transduction of migration in glial tumors and may offer a novel strategy for anti-invasive therapies.


Assuntos
Aspirina/análogos & derivados , Neoplasias Encefálicas/patologia , Glioma/patologia , Lisina/análogos & derivados , Proteínas de Neoplasias/fisiologia , Células-Tronco Neoplásicas/fisiologia , Tromboxano-A Sintase/fisiologia , Ácidos Araquidônicos/metabolismo , Aspirina/farmacologia , Astrócitos/efeitos dos fármacos , Astrócitos/enzimologia , Astrócitos/fisiologia , Benzofuranos/farmacologia , Neoplasias Encefálicas/enzimologia , Neoplasias Encefálicas/genética , Adesão Celular/efeitos dos fármacos , Movimento Celular/fisiologia , Indução Enzimática , Inibidores Enzimáticos/farmacologia , Proteínas de Ligação ao GTP/metabolismo , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Glioma/enzimologia , Glioma/genética , Humanos , Imidazóis/farmacologia , Indometacina/farmacologia , Lisina/farmacologia , Modelos Biológicos , Proteínas de Neoplasias/antagonistas & inibidores , Proteínas de Neoplasias/biossíntese , Células-Tronco Neoplásicas/efeitos dos fármacos , Células-Tronco Neoplásicas/enzimologia , Oligodendroglia/efeitos dos fármacos , Oligodendroglia/enzimologia , Oligodendroglia/fisiologia , Ácidos Pentanoicos/farmacologia , Fenótipo , Piridinas/farmacologia , RNA Mensageiro/biossíntese , RNA Neoplásico/biossíntese , Transdução de Sinais , Tromboxano B2/biossíntese , Tromboxano-A Sintase/antagonistas & inibidores , Tromboxano-A Sintase/biossíntese , Tromboxano-A Sintase/genética , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/enzimologia , Células Tumorais Cultivadas/fisiologia
3.
Nucleic Acids Res ; 26(7): 1793-800, 1998 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9512554

RESUMO

Tyrosine hydroxylase (TH) is expressed specifically in catecholaminergic cells. We have identified a novel regulatory sequence in the upstream region of the bovine TH gene promoter formed by a dyad symmetry element (DSE1;-352/-307 bp). DSE1 supports TH promoter activity in TH-expressing bovine adrenal medulla chromaffin (BAMC) cells and inhibits promoter activity in non-expressing TE671 cells. DNase I footprinting of relaxed TH promoter DNA showed weak binding of nuclear BAMC cell proteins to a short sequence in the right DSE1 arm. In BAMC cells, deletion of the right arm markedly reduced the expression of luciferase from the TH promoter. However, deletion of the left DSE1 arm or its reversed orientation (RevL) also inactivated the TH promoter. In supercoiled TH promoter, DSE1 assumes a cruciform-like conformation i.e., it binds cruciform-specific 2D3 antibody, and S1 nuclease-cleavage and OsO4-modification assays have identified an imperfect cruciform extruded by the DSE1. DNase I footprinting of supercoiled plasmid showed that cruciformed DSE1 is targeted by nuclear proteins more efficiently than the linear duplex isomer and that the protected site encompasses the left arm and center of DSE1. Our results suggest that the disruption of intrastrand base-pairing preventing cruciform formation and protein binding to DSE1 is responsible for its inactivation in DSE1 mutants. DSE1 cruciform may act as a target site for activator (BAMC cells) and repressor (TE671) proteins. Its extrusion emerges as a novel mechanism that controls cell-specific promoter activity.


Assuntos
Medula Suprarrenal/enzimologia , Células Cromafins/enzimologia , DNA Super-Helicoidal/química , Conformação de Ácido Nucleico , Regiões Promotoras Genéticas , Sequências Reguladoras de Ácido Nucleico , Tirosina 3-Mono-Oxigenase/biossíntese , Tirosina 3-Mono-Oxigenase/genética , Animais , Sequência de Bases , Bovinos , Linhagem Celular , Células Cultivadas , DNA Super-Helicoidal/efeitos dos fármacos , DNA Super-Helicoidal/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Humanos , Luciferases/biossíntese , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Neuroblastoma , Especificidade de Órgãos , Tetróxido de Ósmio/farmacologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes/biossíntese , Deleção de Sequência , Transfecção , Células Tumorais Cultivadas
4.
J Neurochem ; 67(1): 26-36, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8666999

RESUMO

The cis elements mediating activation of the tyrosine hydroxylase gene by angiotensin II were examined by transfecting tyrosine hydroxylase promoter-luciferase constructs into cultured bone adrenal medullary cells. Angiotensin II-responsive elements are located within -54/+25-bp and -269/-55-bp promoter regions and were identified, respectively, as cyclic AMP (CRE)- and 12-O-tetradecanoylphorbol 13-acetate responsive element (TRE)-like sequences. Unlike CRE, TRE also supports basal promoter activity. Mutations of TRE or CRE that reduced angiotensin II stimulation abolished in vitro binding of nuclear proteins to those elements, suggesting that proteins forming CRE- and TRE-inducible complexes may mediate angiotensin II stimulation. The TRE is adjacent to a dyad symmetry element. Those two sites form a common regulatory unit in which the dyad symmetry element acts as a repressor of the TRE site. Isolated dyad symmetry element did not bind nuclear proteins in vitro. In supercoiled DNA it exhibited S1 nuclease sensitivity and was recognized by a DNA cruciform-specific antibody consistent with the extrusion of a cruciform structure that overlaps with the TRE. A mutation that abolished formation of the cruciform correlated with a loss of repressor activity. We propose a novel model of tyrosine hydroxylase gene regulation in which functions of the TRE are modulated via structural transition in the adjacent DNA.


Assuntos
Angiotensina II/genética , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/genética , Endopeptidases , Proteínas de Fusão Oncogênica/genética , Proteínas Oncogênicas , Endonucleases Específicas para DNA e RNA de Cadeia Simples/genética , Tirosina 3-Mono-Oxigenase/genética , Animais , Sequência de Bases , Bovinos , Células Cultivadas/enzimologia , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , DNA/análise , DNA/química , DNA/metabolismo , Regulação Enzimológica da Expressão Gênica/genética , Teste de Complementação Genética , Dados de Sequência Molecular , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Conformação de Ácido Nucleico , Proteínas de Fusão Oncogênica/metabolismo , Regiões Promotoras Genéticas/genética , Proteínas Proto-Oncogênicas , Endonucleases Específicas para DNA e RNA de Cadeia Simples/química , Ubiquitina Tiolesterase
5.
Am J Med Sci ; 299(2): 87-93, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2301455

RESUMO

Clinical features, microbiology, and predisposing factors are described in 56 patients with bacterial endocarditis (BE) treated over a 12-year period at a small community hospital in Hawaii. The average age of patients was 52.0 years. The mean duration of symptoms was 28.8 days (range 1 to 240 days). Streptococci was the most frequently identified causative organism, present in 61% of the cases. Gram-negative bacilli were isolated from six patients (11%). Fourteen patients (25%) required cardiac surgery; the most common condition leading to surgery was severe valvular insufficiency, followed by congestive heart failure and recurrent embolism. Eighty-two percent of the patients in the series survived. The leading causes of death were congestive heart failure and cerebrovascular accidents.


Assuntos
Endocardite Bacteriana/epidemiologia , Hospitais Comunitários , Adulto , Idoso , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/epidemiologia , Infecções Bacterianas/terapia , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/terapia , Ecocardiografia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/terapia , Feminino , Bactérias Gram-Negativas/isolamento & purificação , Infecções por Haemophilus/diagnóstico , Infecções por Haemophilus/epidemiologia , Infecções por Haemophilus/terapia , Havaí , Próteses Valvulares Cardíacas , Humanos , Incidência , Masculino , Micrococcus/isolamento & purificação , Pessoa de Meia-Idade , Prognóstico , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/terapia , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/terapia , Transtornos Relacionados ao Uso de Substâncias/complicações
6.
FEBS Lett ; 255(2): 361-4, 1989 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-2551737

RESUMO

An S-adenosyl-L-methionine:DNA-methyltransferase, termed M.BnaI, was purified from Bacillus natto B3364 strain by successive column chromatography. The molecular weight determined by gel filtration was 37 kDa for M.BnaI. Analysis of methyltransferase by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed correspondence of the M.BnaI activity with one protein band at a molecular weight of 35 kDa. Sequencing of pUC19 DNA methylated with M.BnaI showed the cytosine-5 methylation in the BnaI recognition sequence GGAT decreases CC at the position indicated by the arrow.


Assuntos
Bacillus/enzimologia , DNA-Citosina Metilases/isolamento & purificação , Sequência de Bases , Cromatografia , Cromatografia por Troca Iônica , DNA-Citosina Metilases/metabolismo , Durapatita , Eletroforese em Gel de Poliacrilamida , Hidroxiapatitas , Dados de Sequência Molecular , Peso Molecular , Especificidade por Substrato
7.
Gene ; 80(2): 363-8, 1989 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-2583516

RESUMO

By assaying the yield of phage SPO1 we have identified a new restriction-modification activity in the Bacillus natto B3364 strain. A class II restriction endonuclease, BnaI, isolated from the crude extract of B3364 cells was shown to be a true isoschizomer of the BamHI endonuclease. The Mr, stability and optimal conditions required for DNA digestion were determined for BnaI. Although both enzymes show the same specificity, BnaI and BamHI differ from each other in all the properties specified above.


Assuntos
Bacillus/enzimologia , Desoxirribonuclease BamHI/metabolismo , Sítios de Ligação , Desoxirribonuclease BamHI/isolamento & purificação , Glicerol/farmacologia , Concentração de Íons de Hidrogênio , Isoenzimas/isolamento & purificação , Isoenzimas/metabolismo , Peso Molecular , Cloreto de Sódio , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...